Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6526
Nature's Sunshine
NATR
$353M
| $4K | ﹤0.01% |
324
-559
| -63% | -$7.64K |
|
6527
NRC Health Common Stock
NRC
$433M
| $4K | ﹤0.01% |
303
-262
| -46% | -$3.7K |
|
6528
Preformed Line Products
PLPC
$2.3B
| $4K | ﹤0.01% |
79
-137
| -63% | -$6.43K |
|
6529
CALL
PTC
PTC
$15.1B
| $4K | ﹤0.01% |
100
-3,000
| -97% | -$104K |
|
6530
CALL
Rigel Pharmaceuticals
RIGL
$749M
| $4K | ﹤0.01% |
130
-10
| -7% | -$274 |
|
6531
Shake Shack
SHAK
$3B
| $4K | ﹤0.01% |
+75
| New | +$3.37K |
|
|
SHYF
6532
DELISTED
The Shyft Group
SHYF
| $4K | ﹤0.01% |
1,041
-1,759
| -63% | -$9.13K |
|
6533
Sasol
SSL
$7.01B
| $4K | ﹤0.01% |
110
-7,324
| -99% | -$263K |
|
|
SVM
6534
PUT
Silvercorp Metals
SVM
$2.39B
| $4K | ﹤0.01% |
4,100
-21,900
| -84% | -$29.1K |
|
6535
Invesco Solar ETF
TAN
$1.45B
| $4K | ﹤0.01% |
100
-200
| -67% | -$7.71K |
|
6536
PUT
Tidewater
TDW
$3.85B
| $4K | ﹤0.01% |
6
-31
| -84% | -$27.6K |
|
6537
Tandem Diabetes Care
TNDM
$1.34B
| $4K | ﹤0.01% |
29
-39
| -57% | -$5.07K |
|
6538
ReposiTrak
TRAK
$156M
| $4K | ﹤0.01% |
288
-487
| -63% | -$5.69K |
|
6539
Twin Disc
TWIN
$343M
| $4K | ﹤0.01% |
251
-220
| -47% | -$3.98K |
|
6540
PUT
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
| $4K | ﹤0.01% |
200
-1,400
| -88% | -$31.4K |
|
6541
UFP Technologies
UFPT
$2.49B
| $4K | ﹤0.01% |
183
-162
| -47% | -$3.67K |
|
6542
United States Lime & Minerals
USLM
$3.38B
| $4K | ﹤0.01% |
300
-260
| -46% | -$3.57K |
|
6543
Varonis Systems
VRNS
$4.98B
| $4K | ﹤0.01% |
489
-17,523
| -97% | -$187K |
|
6544
CALL
W&T Offshore
WTI
$484M
| $4K | ﹤0.01% |
700
-8,600
| -92% | -$49.9K |
|
|
ZEUS
6545
DELISTED
Olympic Steel
ZEUS
| $4K | ﹤0.01% |
283
-1,247
| -82% | -$18.4K |
|
|
IVAC
6546
DELISTED
Intevac Inc
IVAC
| $4K | ﹤0.01% |
722
-2,141
| -75% | -$14.5K |
|
|
AE
6547
DELISTED
Adams Resources & Energy Inc
AE
| $4K | ﹤0.01% |
62
-59
| -49% | -$3.62K |
|
|
DXYN
6548
DELISTED
Dixie Group Inc
DXYN
| $4K | ﹤0.01% |
447
-405
| -48% | -$3.56K |
|
|
MCBC
6549
DELISTED
Macatawa Bank Corp
MCBC
| $4K | ﹤0.01% |
796
-696
| -47% | -$3.72K |
|
|
MIXT
6550
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $4K | ﹤0.01% |
749
-2,566
| -77% | -$16.1K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.